Centessa Pharmaceuticals (CNTA) EPS (Weighted Average and Diluted): 2022-2025
Historic EPS (Weighted Average and Diluted) for Centessa Pharmaceuticals (CNTA) over the last 4 years, with Sep 2025 value amounting to -$0.41.
- Centessa Pharmaceuticals' EPS (Weighted Average and Diluted) fell 10.81% to -$0.41 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.90, marking a year-over-year decrease of 25.00%. This contributed to the annual value of -$2.06 for FY2024, which is 31.21% down from last year.
- As of Q3 2025, Centessa Pharmaceuticals' EPS (Weighted Average and Diluted) stood at -$0.41, which was down 7.89% from -$0.38 recorded in Q2 2025.
- In the past 5 years, Centessa Pharmaceuticals' EPS (Weighted Average and Diluted) ranged from a high of -$0.20 in Q1 2025 and a low of -$0.91 during Q4 2024.
- Moreover, its 3-year median value for EPS (Weighted Average and Diluted) was -$0.38 (2025), whereas its average is -$0.42.
- In the last 5 years, Centessa Pharmaceuticals' EPS (Weighted Average and Diluted) surged by 62.32% in 2023 and then crashed by 145.95% in 2024.
- Centessa Pharmaceuticals' EPS (Weighted Average and Diluted) (Quarterly) stood at -$0.45 in 2022, then increased by 17.78% to -$0.37 in 2023, then tumbled by 145.95% to -$0.91 in 2024, then dropped by 10.81% to -$0.41 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$0.41 for Q3 2025, versus -$0.38 for Q2 2025 and -$0.20 for Q1 2025.